LSA
LEGN icon

Leonteq Securities AG’s Legend Biotech LEGN Stock Holding History

Leonteq Securities AG’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$26.9K – 1244
2023
Q3 		$26.9K Hold
400
– – ﹤0.01% 908
2023
Q2 		$27.6K Sell
400
-750
-65% -$49K ﹤0.01% 925
2023
Q1 		$55.5K Sell
1,150
-745
-39% -$36.4K ﹤0.01% 781
2022
Q4 		$94.6K Sell
1,895
-1,062
-36% -$51.5K ﹤0.01% 677
2022
Q3 		$121K Sell
2,957
-293
-9% -$13.8K ﹤0.01% 613
2022
Q2 		$179K Sell
3,250
-448
-12% -$18.9K 0.01% 574
2022
Q1 		$134K Sell
3,698
-3,268
-47% -$129K ﹤0.01% 672
2021
Q4 		$325K Buy
+6,966
New +$353K 0.01% 534

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Leonteq Securities AG's LEGN Position: Q4 2023 in Review

Leonteq Securities AG sold out of Legend Biotech (LEGN) in Q4 2023, closing a stake of 400 shares — an estimated $26.9K sold.

Leonteq Securities AG first reported a position in LEGN in Q4 2021 and held it in 8 quarters. The position peaked at $325K in Q4 2021. 206 funds tracked by Wall St. Rank hold LEGN as of Q4 2023.

  • Leonteq Securities AG reported no remaining Legend Biotech position as of Q4 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 400 Legend Biotech shares in Q4 2023, an estimated $26.9K.
  • Leonteq Securities AG first reported a position in Legend Biotech in Q4 2021 and held it in 8 quarters.
  • Leonteq Securities AG's Legend Biotech position peaked at $325K in Q4 2021.
  • 206 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2023.

Based on Leonteq Securities AG's 13F filing for Q4 2023, filed 11 Mar 2026.